Interferon-γ modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis

被引:98
作者
Pouly, S [1 ]
Becher, B [1 ]
Blain, M [1 ]
Antel, JP [1 ]
机构
[1] Montreal Neurol Hosp & Inst, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada
关键词
apoptosis; cytotoxicity; Fas; human; IFN-gamma; oligodendrocytes; TNF-alpha;
D O I
10.1093/jnen/59.4.280
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Interferon gamma (IFN-gamma) has been shown to be produced within multiple sclerosis (MS) lesions by infiltrating lymphocytes: systemic administration of this cytokine induces exacerbation of the disease. The aim of the current study was to establish the contribution of IFN-gamma to oligodendrocyte (OL) injury. Our studies utilized cultured human OLs, obtained by dissociation of surgically derived non-MS adult brain tissue. Neither cell survival nor myelin basic protein (MBP) gene expression were affected after 96 hours of treatment with IFN-gamma (100 U/ml), as assessed by LDH release, nucleosome enrichment assay, and RT-PCR. Expression of the death receptor Fas (CD95, APO-1) was, however, significantly increased. Furthermore, IFN-gamma-treated OLs became susceptible to Fas-mediated apoptosis when compared with untreated cells, and were protected by pretreatment with the caspase inhibitor ZVAD. TNF-alpha augmented the IFN-gamma-induced effect. Our results thus indicate that IFN-gamma is not directly cytotoxic for human OLs in culture, but could indirectly modulate functional injury-related responses by upregulating Fas on the cell surface.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 35 条
[11]   Adoptively transferred EAE in mice bearing the lpr mutation [J].
Clark, RB ;
Grunnet, M ;
Lingenheld, EG .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (03) :315-319
[12]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain [J].
Dowling, P ;
Shang, GF ;
Raval, S ;
Menonna, J ;
Cook, S ;
Husar, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1513-1518
[13]   Cell death and birth in multiple sclerosis brain [J].
Dowling, P ;
Husar, W ;
Menonna, J ;
Donnenfeld, H ;
Cook, S ;
Sidhu, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 149 (01) :1-11
[14]   Multiple sclerosis: Fas signaling in oligodendrocyte cell death [J].
DSouza, SD ;
Bonetti, B ;
Balasingam, V ;
Cashman, NR ;
Barker, PA ;
Troutt, AB ;
Raine, CS ;
Antel, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2361-2370
[15]   Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein [J].
Elliott, EA ;
McFarland, HI ;
Nye, SH ;
Cofiell, R ;
Wilson, TM ;
Wilkins, JA ;
Squinto, SP ;
Matis, LA ;
Mueller, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1602-1612
[16]   Primary demyelination in transgenic mice expressing interferon-gamma [J].
Horwitz, MS ;
Evans, CF ;
McGavern, DB ;
Rodriguez, M ;
Oldstone, MBA .
NATURE MEDICINE, 1997, 3 (09) :1037-1041
[17]   MYELIN BASIC-PROTEIN CONTENT OF AGGREGATING RAT-BRAIN CELL-CULTURES TREATED WITH CYTOKINES AND/OR DEMYELINATING ANTIBODY - EFFECTS OF MACROPHAGE ENRICHMENT [J].
LOUGHLIN, AJ ;
HONEGGER, P ;
WOODROOFE, MN ;
COMTE, V ;
MATTHIEU, JM ;
CUZNER, ML .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 37 (05) :647-653
[18]   Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice [J].
Malipiero, U ;
Frei, K ;
Spanaus, KS ;
Agresti, C ;
Lassmann, H ;
Hahne, M ;
Tschopp, J ;
Eugster, HP ;
Fontana, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3151-3160
[19]   Fas has a crucial role in the progression of experimental autoimmune encephalomyelitis [J].
Okuda, Y ;
Bernard, CCA ;
Fujimura, H ;
Yanagihara, T ;
Sakoda, S .
MOLECULAR IMMUNOLOGY, 1998, 35 (05) :317-326
[20]  
PANITCH HS, 1987, LANCET, V1, P893